Singapore markets closed

ESSA Pharma Inc. (EPIX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.88-0.07 (-1.01%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
21,355
21,323
24,415
24,259
12,146
Selling general and administrative
11,208
11,366
12,280
12,775
11,264
Total operating expenses
31,865
32,134
36,960
37,144
23,520
Operating income or loss
-31,865
-32,134
-36,960
-37,144
-23,520
Interest expense
4.592
6.942
13.746
22.22
618.109
Total other income/expenses net
513.002
6.529
22.039
90.983
-155.707
Income before tax
-25,803
-26,581
-35,215
-36,840
-23,734
Income tax expense
-
1.6
-111.821
-34.349
-288.647
Income from continuing operations
-25,805
-26,582
-35,103
-36,805
-23,445
Net income
-25,805
-26,582
-35,103
-36,805
-23,445
Net income available to common shareholders
-25,805
-26,582
-35,103
-36,805
-23,445
Basic EPS
-0.60
-0.60
-0.80
-0.96
-1.04
Diluted EPS
-0.60
-0.60
-0.80
-0.96
-1.04
Basic average shares
44,090
44,090
44,038
38,480
22,444
Diluted average shares
44,090
44,090
44,038
38,480
22,444